Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.

Tumor cells have increased metabolic requirements to maintain rapid growth. In particular, a highly lipogenic phenotype is a hallmark of many tumor types, including prostate. Cancer cells also have increased turnover of nicotinamide adenine dinucleotide (NAD(+)), a coenzyme involved in multiple meta...

Full description

Bibliographic Details
Main Authors: Sarah C Bowlby, Michael J Thomas, Ralph B D'Agostino, Steven J Kridel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3387004?pdf=render
_version_ 1819019885934542848
author Sarah C Bowlby
Michael J Thomas
Ralph B D'Agostino
Steven J Kridel
author_facet Sarah C Bowlby
Michael J Thomas
Ralph B D'Agostino
Steven J Kridel
author_sort Sarah C Bowlby
collection DOAJ
description Tumor cells have increased metabolic requirements to maintain rapid growth. In particular, a highly lipogenic phenotype is a hallmark of many tumor types, including prostate. Cancer cells also have increased turnover of nicotinamide adenine dinucleotide (NAD(+)), a coenzyme involved in multiple metabolic pathways. However, a specific role for NAD(+) in tumor cell lipogenesis has yet to be described. Our studies demonstrate a novel role for the NAD(+)-biosynthetic enzyme Nicotinamide phosphoribosyltransferase (Nampt) in maintaining de novo lipogenesis in prostate cancer (PCa) cells. Inhibition of Nampt reduces fatty acid and phospholipid synthesis. In particular, short chain saturated fatty acids and the phosphatidylcholine (PC) lipids into which these fatty acids are incorporated were specifically reduced by Nampt inhibition. Nampt blockade resulted in reduced ATP levels and concomitant activation of AMP-activated protein kinase (AMPK) and phosphorylation of acetyl-CoA carboxylase (ACC). In spite of this, pharmacological inhibition of AMPK was not sufficient to fully restore fatty acid synthesis. Rather, Nampt blockade also induced protein hyperacetylation in PC-3, DU145, and LNCaP cells, which correlated with the observed decreases in lipid synthesis. Moreover, the sirtuin inhibitor Sirtinol, and the simultaneous knockdown of SIRT1 and SIRT3, phenocopied the effects of Nampt inhibition on fatty acid synthesis. Altogether, these data reveal a novel role for Nampt in the regulation of de novo lipogenesis through the modulation of sirtuin activity in PCa cells.
first_indexed 2024-12-21T03:42:26Z
format Article
id doaj.art-f15d548e250040ac91c57d3dfa22aaea
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T03:42:26Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f15d548e250040ac91c57d3dfa22aaea2022-12-21T19:17:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0176e4019510.1371/journal.pone.0040195Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.Sarah C BowlbyMichael J ThomasRalph B D'AgostinoSteven J KridelTumor cells have increased metabolic requirements to maintain rapid growth. In particular, a highly lipogenic phenotype is a hallmark of many tumor types, including prostate. Cancer cells also have increased turnover of nicotinamide adenine dinucleotide (NAD(+)), a coenzyme involved in multiple metabolic pathways. However, a specific role for NAD(+) in tumor cell lipogenesis has yet to be described. Our studies demonstrate a novel role for the NAD(+)-biosynthetic enzyme Nicotinamide phosphoribosyltransferase (Nampt) in maintaining de novo lipogenesis in prostate cancer (PCa) cells. Inhibition of Nampt reduces fatty acid and phospholipid synthesis. In particular, short chain saturated fatty acids and the phosphatidylcholine (PC) lipids into which these fatty acids are incorporated were specifically reduced by Nampt inhibition. Nampt blockade resulted in reduced ATP levels and concomitant activation of AMP-activated protein kinase (AMPK) and phosphorylation of acetyl-CoA carboxylase (ACC). In spite of this, pharmacological inhibition of AMPK was not sufficient to fully restore fatty acid synthesis. Rather, Nampt blockade also induced protein hyperacetylation in PC-3, DU145, and LNCaP cells, which correlated with the observed decreases in lipid synthesis. Moreover, the sirtuin inhibitor Sirtinol, and the simultaneous knockdown of SIRT1 and SIRT3, phenocopied the effects of Nampt inhibition on fatty acid synthesis. Altogether, these data reveal a novel role for Nampt in the regulation of de novo lipogenesis through the modulation of sirtuin activity in PCa cells.http://europepmc.org/articles/PMC3387004?pdf=render
spellingShingle Sarah C Bowlby
Michael J Thomas
Ralph B D'Agostino
Steven J Kridel
Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
PLoS ONE
title Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
title_full Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
title_fullStr Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
title_full_unstemmed Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
title_short Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
title_sort nicotinamide phosphoribosyl transferase nampt is required for de novo lipogenesis in tumor cells
url http://europepmc.org/articles/PMC3387004?pdf=render
work_keys_str_mv AT sarahcbowlby nicotinamidephosphoribosyltransferasenamptisrequiredfordenovolipogenesisintumorcells
AT michaeljthomas nicotinamidephosphoribosyltransferasenamptisrequiredfordenovolipogenesisintumorcells
AT ralphbdagostino nicotinamidephosphoribosyltransferasenamptisrequiredfordenovolipogenesisintumorcells
AT stevenjkridel nicotinamidephosphoribosyltransferasenamptisrequiredfordenovolipogenesisintumorcells